Blogs

The Future Pharma Supply Chain: Be Very Afraid?

FDA Cites "Shadow" Heparin Manufacturing Plants in China

Astra Zeneca CEO, Dick Gephardt Emphasize Drug Manufacturing's Strategic Importance; Cry Me a River

Will the High Costs of Analytics Permit Future Cases of Heparin Contamination?

Competing in a Global Marketplace: Reports from Julian WIlkins and John Fielding

California’s e-Pedigree Law: Only 2,312 Days to Go?

Like a Broken Record: California Delays Pedigree Legislation

Is Synthetic Heparin the Solution?

Managing Change: What Keeps Pharma CEO’s Awake at Night

Who’s on Third? - Benchmarking Pharma Supply Chain Risk Management Practices